Suppr超能文献

右美托咪定在双重刺激下喙突入路臂丛神经阻滞中的作用

The effect of dexmedetomidine in coracoid approach brachial plexus block under dual stimulation.

作者信息

He Wen-Sheng, Liu Zhuo, Wu Zhen-Yu, Sun Hai-Jun, Yang Xiao-Chun, Wang Xiu-Li

机构信息

Department of Anesthesia, The Third Hospital of Hebei Medical University, Shijiazhuang.

Department of Anesthesia, The First Hospital of Qinhuangdao Affiliated to Hebei Medical University, Qinhuangdao, Hebei Province, China.

出版信息

Medicine (Baltimore). 2018 Sep;97(39):e12240. doi: 10.1097/MD.0000000000012240.

Abstract

BACKGROUND

Coracoid approach brachial plexus block (CABPB) is safe and effective for clinical anesthesia and analgesia. Dual stimulation can enhance the block effect of CABPB when using nerve stimulator. Dexmedetomidine is a highly selective α-adrenoceptor agonist and it can prolong the duration of anesthesia when it is added into local anesthetics. The aim of this study was to assess the effects of dexmedetomidine on the duration of anesthesia and the effective postoperative analgesia time when it was mixed with ropivacaine for CABPB under dual stimulation.

METHODS

A total of 60 patients were randomly assigned into 2 groups (groups D and C), 30 patients in each group. CABPB were guided by nerve stimulator under dual stimulation. Each patient received 40 mL of 0.375% ropivacaine (group C), or 40 mL of 0.375% ropivacaine mixed with 1 μg/kg dexmedetomidine (group D). The duration of anesthesia, the effective postoperative analgesia time, sensory and motor block onset time, visual analog scale (VAS), and the cumulative dose of rescue tramadol were recorded.

RESULTS

Twenty-eight patients in each group were analyzed. The duration of anesthesia was longer in group D as compared with group C (759 vs 634 minutes, P < .05) and the effective postoperative analgesia time was longer in group D as compared with group C (986 vs 789 minutes, P < .05) too. The onset time of sensory and motor blocks were not significantly different between the 2 groups (P > .05). The VAS was similar in the 2 groups at 6 and 12 hours after block (P > .05), but it was lower in group D at 24 hours after block as compared to group C (P < .05). The cumulative dose of rescue tramadol during the first 48 hours postoperative period was significantly lower in group D as compared to group C (P < .05). No significant changes were observed in vital signs in either group.

CONCLUSION

The addition of 1 μg/kg dexmedetomidine to ropivacaine extends the duration of anesthesia and the effective postoperative analgesia time for CABPB under dual stimulation. The VAS at 24 hours after block and the demand for rescue tramadol during the first 48 hours postoperative period are lower as well without side effects in the study group.(Registered in ClinicalTrials.gov id. NCT02961361).

摘要

背景

喙突入路臂丛神经阻滞(CABPB)用于临床麻醉和镇痛安全有效。使用神经刺激器时,双重刺激可增强CABPB的阻滞效果。右美托咪定是一种高选择性α-肾上腺素能受体激动剂,加入局麻药中可延长麻醉时间。本研究旨在评估右美托咪定与罗哌卡因混合用于双重刺激下的CABPB时,对麻醉持续时间和术后有效镇痛时间的影响。

方法

将60例患者随机分为2组(D组和C组),每组30例。在双重刺激下,采用神经刺激器引导进行CABPB。每组患者分别接受40ml 0.375%罗哌卡因(C组)或40ml 0.375%罗哌卡因与1μg/kg右美托咪定混合液(D组)。记录麻醉持续时间、术后有效镇痛时间、感觉和运动阻滞起效时间(视觉模拟评分法(VAS))以及曲马多补救用药的累积剂量。

结果

每组28例患者纳入分析。D组的麻醉持续时间长于C组(759分钟 vs 634分钟,P<0.05),D组的术后有效镇痛时间也长于C组(986分钟 vs 789分钟,P<0.05)。两组感觉和运动阻滞的起效时间差异无统计学意义(P>0.05)。两组在阻滞后6小时和12小时时VAS相似(P>0.05),但在阻滞后24小时时,D组的VAS低于C组(P<0.05)。术后48小时内,D组曲马多补救用药的累积剂量显著低于C组(P<0.05)。两组患者生命体征均未观察到明显变化。

结论

在双重刺激下,罗哌卡因中加入1μg/kg右美托咪定可延长CABPB 的麻醉持续时间和术后有效镇痛时间。研究组在阻滞后24小时时的VAS以及术后48小时内曲马多补救用药的需求也较低,且无副作用。(注册于ClinicalTrials.gov,编号:NCT02961361)

相似文献

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验